Fiocruz and bioMérieux are opening on Monday (10) a diagnostics research and innovation center in Jacarepagua (RJ).
The French company ceded the entire space to the organization, which will begin work there in March 2026.
The center will include research and development projects for inputs and diagnostic kits for the unified support system. Fiocruz says the initiative will expand production capacity, modernize technologies, automate processes, and include new technology transfer projects.
The organization also states that the space will reduce production time and enhance national independence in diagnostics.
Fiocruz President Mario Moreira said the agreement reinforces the historic partnership between Brazil and France. The center is “a strategic step to expand the national capacity for production and innovation in the field of diagnostics,” with a direct impact on confronting health emergencies. According to him, the goal is to offer tools that are “accurate, timely and sustainable”, in line with technological progress.
with Diego Alejandro, Karina Matias and Victoria Cocolo
Current link: Did you like this text? Subscribers can access seven free accesses from any link per day. Just click on the blue letter F below.
Your subscription may be worth more than that
Do you already know the benefits of being a Folha subscriber? In addition to access to reports and columns, you have exclusive newsletters (find out here). You can also download our free app from the Apple Store or Google Play to receive alerts for the day’s top stories. Your subscription helps us provide high-quality, independent journalism. Thanks!
Your subscription is worth a lot
More than 180 reports and analyzes are published daily. A team of over 200 columnists and bloggers. Professional journalism monitors public authorities, reports useful and inspiring news, challenges social media intolerance, and draws a clear line between truth and lies. How much does it cost to help produce this content?
Subscribe for R$ 1.90 for the first month
About The Author
